The serodiagnosis of infections caused by verocytotoxin-producing Escherichia coli

Journal of Applied Microbiology

Volumn 86, Issue 5, 1999, Pages 731-740

  Chart, H ^a   Jenkins, C ^a  

^a CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; DISEASES; EPITOPES; ESCHERICHIA COLI;

'CURRENT; BRUCELLA ABORTUS; CULTURABLE; E COLI SEROGROUPS; E. COLI O157; E.COLI O157; ESCHERICHIA COLI O157; HAEMORRHAGIC COLITIS; LIPOPOLYSACCHARIDES; VEROCYTOTOXIN;

ANTIBODIES;

BACTERIUM LIPOPOLYSACCHARIDE; CROSS REACTING ANTIBODY; EPITOPE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VEROTOXIN;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; BACTERIAL INFECTION; BRUCELLA ABORTUS; CITROBACTER FREUNDII; CROSS REACTION; DISEASE ASSOCIATION; ESCHERICHIA COLI O157; HEMOLYTIC UREMIC SYNDROME; HEMORRHAGIC COLITIS; NONHUMAN; REVIEW; SALMONELLA; SEQUENCE HOMOLOGY; SERODIAGNOSIS; VIBRIO CHOLERAE; YERSINIA ENTEROCOLITICA;

EID: 0032925885     PISSN: 13645072     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2672.1999.00766.x     Document Type: Review

References (88)

1. Banatvala, N., Magnano, A.R., Cartter, M.L. et al. (1996) Meat grinders and molecular epidemiology: two supermarket outbreaks of Escherichia coli O157: H7 infection. Journal of Infectious Diseases 173, 480-483.
2. Barrett, T.J., Green, J.H., Griffin, P.M. et al. (1991) Enzyme-linked immunosorbent assays for detecting antibodies to Shiga-like toxin-I, Shiga-like toxin-II, and Escherichia coli O157: H7 lipopolysaccharide in human serum. Current Microbiology 23, 189-195.
3. Biclaszewska, M., Janda, J., Blahova, K. et al. (1996) Verocytotoxin-producing Escherichia coli in children with hemolytic uremic syndrome in the Czech Republic. Clinical Nephrology 46, 42-44.
4. Bitzan, M., Ludwig, K., Klemt, M. et al. (1993) The role of Escherichia coli O157 infections in classical (enteropathic) haemolytic uraemic syndrome: results of a central European, multicentre study. Epidemiology and Infection 110, 183-196.
5. Cameron, A.S., Beers, M.Y., Walker, C.C. et al. (1995) Community outbreak of Hemolytic uremic syndrome attributable to Escherichia coli O111:NM-South Australia. Morbidity and Mortality Weekly Report 44, 550-558.
6. Caprioli, A., Luzzi, I., Rosmini, F. et al. (1992) Hemolytic-uremic syndrome and Vero cytotoxin-producing Escherichia coli infection in Italy. Journal of Infectious Diseases 166, 154-158.
7. Caprioli, A., Luzzi, I., Rosmini, F. et al. (1994b) Communitywide outbreak of Hemolytic-uremic syndrome associated with non-O157 Vero cytotoxin-producing Escherichia coli. Journal of Infectious Diseases 169, 208-211.
8. Caprioli, A., Luzzi, I., Serganti, L.F. et al. (1994a) Frequency and nature of Verocytotoxin 2 (VT2) neutralizing activity (NA) in human and animal sera. In Recent Advances in Verocytotoxin-Producing Escherichia coli Infections ed. Karmali, M. and Goglio, A.G. pp. 353-356. Amsterdam: Elsevier Science.
9. Caroff, M., Bundle, D.R. and Perry, M.B. (1984) Structure of the O-chain of the phenol-phase soluble cellular lipopolysaccharide of Yersinia enterocolitica serotype O9. European Journal of Biochemistry 139, 195-200.
10. Chart, H., Cheasty, T., Cope, D. et al. (1991b) The serological relationship between Yersinia enterocolitica O9 and Escherichia coli O157 using sera from patients with yersiniosis and haemolytic uraemic syndrome. Epidemiology and Infection 107, 349-356.
11. Chart, H., Cheasty, T., Giorgio, T. et al. (1993c) Antigenic cross-reactions between Escherichia coli O157, Vibrio cholerae O1 Inaba and group N Salmonella. Serodiagnosis and Immunotherapy in Infectious Diseases 5, 81-84.
12. Chart, H., Cheasty, T. and Rowe, B. (1996) Serological identification of infection with Verocytotoxin-producing Escherichia coli. Letters in Applied Microbiology 23, 322-324.
13. Chart, H., Evans, J., Chalmers, R.M. et al. (1998b) Escherichia coli O157 serology: false-positive ELISA results caused by human antibodies binding to bovine serum albumin. Letters in Applied Microbiology 27, 76-78.
14. Chart, H. and Jenkins, C. (1998) Salivary antibodies to lipo-polysaccharide antigens of Escherichia coli O157. Lancet 352, 371.
15. Chart, H., Jenkins, C., Smith, H. et al. (1998a) Serum antibodies to secreted proteins in patients infected with Escherichia coli O157 and other VTEC. Epidemiology and Infection 120, 239-243.
16. Chart, H., Jenkins, C., Smith, H. et al. (1998c) Strains of Escherichia coli O157 and O55 express lipopolysaccharides which are structurally distinct and do not share epitopes. Journal of Infectious Diseases 178, 920-921.
17. Chart, H., Law, D., Acheson, D.W.K. et al. (1993c) Patients with haemolytic uraemic syndrome caused by Escherichia coli O157 do not produce serum antibodies to Vero cytotoxin 1 (VT1) or VT2. Journal of Clinical Pathology 46, 1053-1054.
18. Chart, H., Montgomery, S. and Rowe, B. (1994) A rapid immunoblotting procedure for detecting serum antibodies to the lipopolysaccharide of Escherichia coli O157. Letters in Applied Microbiology 18, 100-101.
19. Chart, H., Okubadejo, O.A. and Rowe, B. (1992) The serological relationship between Escherichia coli O157 and Yersinia enterocolitica O9 using sera from patients with brucellosis. Epidemiology and Infection 108, 77-85.
20. Chart, H. and Rowe, B. (1990) Serological identification of infection by Vero cytotoxin producing Escherichia coli in patients with haemolytic uraemic syndrome. Serodiagnosis and Immunotherapy in Infectious Diseases 4, 413-418.
21. Chart, H. and Rowe, B. (1992) Improved detection of infection by Escherichia coli O157 in patients with haemolytic uraemic syndrome by means of IgA class antibodies to lipopolysaccharide. Journal of Infection 24, 257-261.
22. Chart, H. and Rowe, B. (1993) Failure of patients with haemolytic uraemic syndrome to produce IgG class antibodies to Escherichia coli O157 lipopolysaccharide. Serodiagnosis and Immunotherapy in Infectious Diseases 5, 217-219.
23. Chart, H. and Rowe, B. (1997) A simple dot immunoassay for detecting antibodies to the lipopolysaccharide of Verocytotoxin-producing Escherichia coli in patients with haemolytic uraemic syndrome. Journal of Microbiological Methods 28, 85-88.
24. Chart, H., Rowe, B., van der Kar, N. et al. (1991c) Serological identification of Escherichia coli O157 as a cause of HUS in Netherlands. Lancet 337, 437.
25. Chart, H., Said, B., Stokes, N. and Rowe, B. (1993b) Heterogeneity in expression of lipopolysaccharides by strains of Escherichia coli O157. Journal of Infection 27, 237-241.
26. Chart, H., Scotland, S.M. and Rowe, B. (1988) Bacterial antigenic cross-reactions and haemolytic uraemic syndrome. Lancet ii, 510-511.
27. Chart, H., Scotland, S.M. and Rowe, B. (1989a) Serum antibodies to Escherichia coli serotype O157: H7 in patients with hemolytic uremic syndrome. Journal of Clinical Microbiology 27, 285-290.
28. Chart, H., Scotland, S.M., Smith, H.R. et al. (1989b) Antibodies to Escherichia coli O157 in patients with haemorrhagic colitis and haemolytic uraemic syndrome. Journal of Clinical Pathology 42, 973-976.
29. Chart, H., Smith, H.R., Scotland, S.M. et al. (1991a) Serological identification of Escherichia coli O157: H7 infection in haemolytic uraemic syndrome. Lancet 337, 138-140.
30. Chart, H., van der Kar, N., Monnens, L.A.H. et al. (1993a) Serological detection of Verocytotoxin-producing Escherichia coli in patients with haemolytic uraemic syndrome in western Europe. European Journal of Clinical Microbiology and Infectious Diseases 12, 707-709.
31. Chart, H., Willshaw, G.A., Cheasty, T. et al. (1993d) Structure and antigenic properties of Citrobacter freundii lipopolysaccharides. Journal of Applied Bacteriology 74, 583-587.
32. Cheasty, T., Robertson, R., Chart, H. et al. (1998) The use of serodiagnosis in the retrospective investigation of a nursery outbreak associated with Escherichia coli O157: H7. Journal of Clinical Pathology 51, 498-501.
33. Donnenberg, M.S. and Kaper, J.B. (1991) Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector. Infection and Immunity 59, 4310-4317.
34. Foubister, V., Rosenshine, I., Donnenberg, M.S. et al. (1994) The eae B gene of enteropathogenic Escherichia coli is necessary for signal transduction in epithelial cells. Infection and Immunity 62, 3038-3040.
35. Greatorex, J.S. and Thorne, G.M. (1994) Humoral immune response to shiga-like toxins and Escherichia coli O157 lipopolysaccharide in Hemolytic uremic syndrome patients and healthy subjects. Journal of Clinical Microbiology 32, 1172-1178.
36. Gunzer, F. and Karch, H. (1993) Expression of A and B subunits of Shiga-like toxin as fusions with glutathione S-transferase and their potential use in seroepidemiology. Journal of Clinical Microbiology 31, 2604-2610.
37. Jarvis, K.G., Giron, J.A., Jerse, A.E. et al. (1995) Enteropathogenic Escherichia coli contains a putative type III secretion system for the export of proteins involved in attaching and effacing lesion formation. Proceedings of the National Academy of Sciences USA 92, 7996-8000.
38. Jarvis, K.G. and Kaper, J.B. (1996) Secretion of extracellular proteins by enterohemorrhagic Escherichia coli via a putative type III secretion system. Infection and Immunity 64, 4826-4829.
39. Jenkins, C. and Chart, H. (1999) Serodiagnosis of infection with Verocytotoxin-producing Escherichia coli. Journal of Applied Microbiology 86, 569-575.
40. Jerse, A.E., Gicquelais, K.G. and Kaper, J.B. (1991) Plasmid and chromosomal elements involved in the pathogenesis of attaching and effacing Escherichia coli. Infection and Immunity 59, 3869-3875.
41. Kaper, J.B. (1998) EPEC delivers the goods. Trends in Microbiology 169, 169-172.
42. Karmali, M.A. (1989) Infection by Verocytotoxin-producing Escherichia coli. Clinical Microbiology Reviews 2, 15-38.
43. Karmali, M.A., Petric, M., Winkler, M. et al. (1994) Enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Escherichia coli Verocytotoxin I. Journal of Clinical Microbiology 32, 1457-1463.
44. Karmali, M.A., Steele, B.T., Petric, M. et al. (1983) Sporadic cases of haemolytic uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet i, 619-620.
45. Kenny, B. and Finlay, B.B. (1995) Protein secretion by enteropathogenic Escherichia coli is essential for transducing signals to epithelial cells. Proceedings of the National Academy of Sciences USA 92, 7991-7995.
46. Kishore, K., Rattan, A., Bagga, A. et al. (1992) Serum antibodies to Vero cytotoxin-producing Escherichia coli (VTEC) in patients with haemolytic uraemic syndrome. Journal of Medical Microbiology 37, 364-367.
47. Kleanthous, H., Smith, H.R., Scotland, S.M. et al. (1990) Haemolytic uraemic syndromes in the British Isles, 1985-1988; association with Vero cytotoxinproducing Escherichia coli. Part 2. Microbiological aspects. Archives of Diseases of Childhood 65, 722-727.
48. Kobayashi, Y., Maeyama, K., Shiki, Y. et al. (1993) Sporadic case of hemolytic uremic syndrome associated with verotoxin producing Escherichia coli O2: K1: H7. Journal of the Japanese Association for Infectious Diseases 67, 116-121.
49. Konowalchuk, J., Speirs, J.I. and Stavric, S. (1977) Vero response to a cytotoxin of Escherichia coli. Infection and Immunity 18, 775-779.
50. Lingwood, C.A., Law, H., Richardson, S.E. et al. (1987) Glycolipid binding of natural and recombinant Escherichia coli produced Verotoxin in vitro. Journal of Biological Chemistry 262, 8834-8839.
51. Lipsky, B.A., Hook, E.W., Smith, A.A. et al. (1980) Citrobacter infections in humans: Experience at the Seattle veterans administration medical center and a review of the literature. Reviews in Infectious Diseases 2, 746-760.
52. Louie, M., De Azavedo, J., Clarke, R. et al. (1994) Sequence heterogeneity of the eae gene and detection of verotoxin-producing Escherichia coli using serotype-specific primers. Epidemiology and Infection 112, 449-461.
53. Louie, M., De Azavedo, J., Handelsman, M.Y.C. et al. (1993) Expression and characterization of the eae A gene product of Escherichia coli serotype O157: H7. Infection and Immunity 61, 4085-4092.
54. Ludwig, K., Bitzan, M., Zimmerman, S. et al. (1996) Immune response of non-O157 vero toxin-producing Escherichia coli in patients with hemolytic uremic syndrome. Journal of Infectious Diseases 174, 1028-1039.
55. Luzzi, I., Tozzi, A.E., Rizzoni, G. et al. (1995) Detection of serum antibodies to the lipopolysaccharide of Escherichia coli O103 in patients with Hemolytic-uremic syndrome. Journal of Infectious Diseases 171, 514-515.
56. March, S.B. and Ratnam, S. (1986) Sorbitol-MacConkey medium for detection of Escherichia coli O157: H7 associated with hemorrhagic colitis. Journal of Clinical Microbiology 23, 869-872.
57. Milford, D.V., Taylor, C.M., Gutteridge, B. et al. (1990) Haemolytic uraemic syndromes in the British Isles, 1985-1988; association with Vero cytotoxinproducing Escherichia coli. Part 1. Clinical and epidemiological aspects. Archives of Diseases of Childhood 65, 716-721.
58. Morooka, T., Matano, H., Umeda, A. et al. (1995) Indirect hemagglutination assay for antibodies to Escherichia coli lipopolysaccharides O157, O111 and O26 in patients with hemolytic uremic syndrome. Acta Paediatrica Japonica 37, 469-473.
59. Notenboom, R.H., Borczyk, A., Karmali, M.A. et al. (1987) Clinical relevance of a serological cross-reaction between Escherichia coli and Brucella abortus. Lancet ii, 744.
60. O'Brien, A.D. and Holmes, R.K. (1987) Shiga and Shiga-like toxins. Microbiology Reviews 51, 206-220.
61. Park, C.H., Martin, E. A. and White, E.L. (1998) Isolation of non-pathogenic strain of Citrobacter sedlakki which expresses Escherichia coli O157 antigen. Journal of Clinical Microbiology 36, 1408-1409.
62. Perry, M.B. and Bundle, D.R. (1990) Antigenic relationships of the lipopolysaccharides of Escherichia hermanni strains with those of Escherichia coli O157, Brucella melitensis and Brucella abortus. Infection and Immunity 58, 1391-1395.
63. Perry, M.B., MacLean, I. and Griffith, D.W. (1985) Structure of the O-chain polysaccharide of the phenol-phase soluble lipopolysaccharide of Escherichia coli O157: H7. Biochemistry and Cell Biology 64, 21-28.
64. Rice, E.W., Soweres, E.G., Johnson, C.H. et al. (1992) Serological cross-reactions between Escherichia coli O157 and other species of the genus Escherichia. Journal of Clinical Microbiology 30, 1315-1316.
65. Rowe, P., Orbine, E., Lior, H. et al. (1993) A prospective study of exposure to verocytotoxin-producing Escherichia coli among Canadian children with haemolytic uraemic syndrome. Epidemiology and Infection 110, 1-7.
66. Samuel, J.E., Perera, L.P., Ward, S. et al. (1990) Comparison of the glycolipid receptor specificites of Shiga-like toxin type II and Shiga-like toxin type II variants. Infection and Immunity 58, 611-618.
67. Sandulache, R. and Marx, A. (1978) Immunochemical studies on a Yersinia enterocolitica O: 9 lipopolysaccharide cross-reacting with Brucella abortus and Vibrio cholerae extracts. Annals of Microbiology Institute Pasteur 129, 425-435.
68. Schmidt, H., Montag, M., Bockemühl, J., Heesemann, J. and Karch, H. (1993) Shiga-like toxin II-realted cytotoxins in Citrobacter freundii strains from humans and beef samples. Infection and Immunity 61, 534-543.
69. Scotland, S.M., Said, B., Thomas, A. et al. (1994) Ability of human sera to neutralise the activity of Vero toxins VT1, VT2 and variant forms of VT2. FEMS Microbiology Letters 115, 285-290.
70. Scotland, S.M. and Smith, H.R. (1997) Verocytotoxins. In Escherichia coli Mechanisms of Virulence ed. Sussman, M. pp. 257-280. Cambridge: Cambridge University Press.
71. Scotland, S.M., Smith, H.R. and Rowe, B. (1985) Two distinct toxins active on Vero cells from Escherichia coli O157. Lancet ii, 885-886.
72. Sherman, P., Soni, R. and Yeger, H. (1988) Characterization of flagella purified from enterohemorrhagic, vero-cytotoxin-producing Escherichia coli serotype O157: H7. Journal of Clinical Microbiology 26, 1367-1372.
73. Siddons, C.A. and Chapman, P.A. (1993) Detection of serum and faecal antibodies in haemorrhagic colitis caused by Escherichia coli O157. Journal of Medical Microbiology 39, 408-415.
74. Stuart, F.A. and Corbel, M.J. (1982) Identification of a serological cross-reaction between Brucella abortus and Escherichia coli O157. Veterinary Record 110, 202-203.
75. Takeda, T., Nakao, H., Yamanaka, T. et al. (1993) High prevalence of serum antibodies to Verocytotoxins 1 and 2 among healthy adults in Japan. Journal of Infection 27, 211-212.
76. Tesh, V.L., Samuel, J.E., Perera, L.P. et al. (1991) Evaluation of the role of shiga and shiga-like toxins in mediating direct damage to human vascular endothelial cells. Journal of Infectious Diseases 164, 344-352.
77. Thomas, A., Chart, H., Cheasty, T. et al. (1993) Vero cytotoxin-producing Escherichia coli, particularly serogroup O157, associated with human infections in the United Kingdom: 1989-91. Epidemiology and Infection 110, 591-600.
78. Thomas, A., Cheasty, T., Frost, J.A. et al. (1996) Vero cytotoxin-producing Escherichia coli, particularly serogroup O157, associated with human infections in England and Wales: 1992-4. Epidemiology and Infection 117, 1-10.
79. Tyler, S.D., Johnson, H., Lior, H. et al. (1991) Identification of Verotoxin type 2 variant B subunit genes in Escherichia coli by the polymerase chain reaction and restriction fragment length polymorphism analysis. Journal of Clinical Microbiology 29, 1339-1343.
80. Uchida, H., Kanegane, H., Yoshiya, K. et al. (1995) Four cases of hemolytic uremic syndrome associated with serotype O165 verocytotoxin-producing Escherichia coli identified by LPS-solid phase enzyme-linked immunosorbent assay. Journal of the Japanese Association for Infectious Diseases 69, 678-683.
81. Weinstein, D.L., Jackson, M.P., Samuel, J.E. et al. (1988) Cloning and sequencing of Shiga-like toxin II variant from an Escherichia coli strain responsible for edema disease in swine. Journal of Bacteriology 170, 4223-4230.
82. Wells, J.G., Davis, B.R., Wachsmuth, I.K. et al. (1983) Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype. Journal of Clinical Microbiology 18, 512-520.
83. Westphal, O. and Jahn, K. (1965) Bacterial lipopolysaccharides: Extraction with phenol-water and further applications of the procedure. Methods in Carbohydrate Chemistry 5, 83-91.
84. Willshaw, G.A., Scotland, S.M. and Smith, H.R. (1997) Verocytotoxin producing Escherichia coli. In Escherichia coli Mechanisms of Virulence, ed. Sussman, M. pp. 421-448. Cambridge: Cambridge University Press.
85. Wilson, J.B., Clarke, R.C., Renwick, S.A. et al. (1996) Vero cytotoxigenic Escherichia coli infection in dairy farm families. Journal of Infectious Diseases 174, 1021-1027.
86. Yamada, S., Kai, A. and Kudoh, Y. (1994) Serodiagnosis by passive haemagglutination test and verocytotoxin enzyme-linked immunosorbent assay of toxin-producing Escherichia coli infections in patients with hemolytic uremic syndrome. Journal of Clinical Microbiology 32, 955-959.
87. Yamada, S., Matsushita, S., Kai, A. et al. (1993) Detection of Verocytotoxin from stool and serological testing of patients with diarrhea caused by Escherichia coli O157: H7. Microbial Immunology 35, 111-118.
88. Zadik, P.M., Chapman, P.A. and Siddons, C.A. (1993) Use of tellurite for the selection of Verocytotoxigenic Escherichia coli O157. Journal of Medical Microbiology 39, 155-158.